Diphenyl disulfide compounds having an inhibiting activity against the production of Interleukin-1 beta (IL-1 beta ) or the release of Tumor Necrosis Factor alpha (TNF alpha ), which are useful in the treatment or prophylaxis of the diseases such as chronic rheumatism and sepsis are described.
